Telehealth Firms Double-Dip: Patient Care vs. Employer Costs

Telehealth companies are emerging as significant players in managing the rising costs of obesity medications for employers. These services, such as Vida Health and Omada Health, offer lifestyle support but also function to limit spending on drugs like Wegovy and Zepbound. Patients like David Davis have described navigating complex requirements, including trying generic drugs not approved for their condition, before getting insurance approval.

These telehealth providers were hired by employers seeking to minimize weight-related healthcare expenses. While some patients, like Jackie O'Gorman, report positive experiences and goal achievement with telehealth coaching, others face challenges. Dr. Catherine Varney highlights concerns that some telehealth providers offer medical advice outside their scope, pushing patients off crucial medications, which can lead to significant weight regain, similar to discontinuing blood pressure pills.

This practice contrasts with research indicating that stopping obesity drugs often results in rapid weight regain. Despite companies like Virta Health claiming their patients can sustain weight loss, a broader systematic review suggests otherwise. Physicians are raising alarms about these telehealth services prioritizing cost reduction over patient well-being and evidence-based care.